Short Interest in Precision Optics Co., Inc. (NASDAQ:POCI) Decreases By 44.6%

Precision Optics Co., Inc. (NASDAQ:POCIGet Free Report) was the target of a significant decline in short interest in the month of March. As of March 31st, there was short interest totalling 8,200 shares, a decline of 44.6% from the March 15th total of 14,800 shares. Based on an average daily trading volume, of 5,000 shares, the short-interest ratio is presently 1.6 days. Approximately 0.2% of the company’s shares are short sold.

Precision Optics Price Performance

Shares of NASDAQ:POCI opened at $5.53 on Thursday. Precision Optics has a 1 year low of $5.12 and a 1 year high of $6.99. The business has a 50 day simple moving average of $5.74 and a two-hundred day simple moving average of $5.94. The firm has a market capitalization of $33.59 million, a PE ratio of -18.45 and a beta of 0.12. The company has a debt-to-equity ratio of 0.17, a current ratio of 1.82 and a quick ratio of 1.10.

Precision Optics (NASDAQ:POCIGet Free Report) last announced its quarterly earnings results on Wednesday, February 14th. The company reported ($0.13) earnings per share (EPS) for the quarter. The firm had revenue of $4.82 million during the quarter. Precision Optics had a negative net margin of 8.93% and a negative return on equity of 21.74%.

Institutional Trading of Precision Optics

A number of large investors have recently modified their holdings of POCI. BlackRock Inc. purchased a new stake in shares of Precision Optics in the second quarter valued at approximately $39,000. Renaissance Technologies LLC purchased a new stake in shares of Precision Optics in the first quarter valued at approximately $84,000. Vanguard Group Inc. purchased a new stake in shares of Precision Optics in the third quarter valued at approximately $142,000. Morgan Stanley purchased a new stake in shares of Precision Optics in the fourth quarter valued at approximately $195,000. Finally, AMH Equity Ltd purchased a new stake in shares of Precision Optics in the fourth quarter valued at approximately $845,000. Hedge funds and other institutional investors own 13.71% of the company’s stock.

About Precision Optics

(Get Free Report)

Precision Optics Corporation, Inc designs, develops, manufactures, and sells specialized optical and illumination systems and related components primarily in the United States and the European Economic Area. It offers medical instrumentation products, including endoscopes and endocouplers, as well as other custom imaging and illumination products, such as Microprecision lenses and micro medical cameras, and 3D endoscopes for use in minimally invasive surgical procedures by hospitals and physicians.

Featured Stories

Receive News & Ratings for Precision Optics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Precision Optics and related companies with MarketBeat.com's FREE daily email newsletter.